| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.9 |